Russell Darst
About Russell Darst
Russell Darst is a Bioinformatics Engineer currently working at Sangamo Therapeutics, Inc. He has a background in biochemistry and molecular genetics, holding a PhD from the University of Virginia, and has extensive experience in bioinformatics and computational biology.
Work at Sangamo Therapeutics
Russell Darst currently serves as a Bioinformatics Engineer at Sangamo Therapeutics, Inc., a position he has held since 2022. His work focuses on the application of bioinformatics in the field of gene therapy and genomic medicine. He contributes to the analysis and interpretation of biological data, which is crucial for advancing therapeutic strategies in the company.
Previous Experience in Bioinformatics
Before joining Sangamo Therapeutics, Russell Darst worked at Phylagen as a Bioinformatics Engineer from 2021 to 2022. He also held the position of Computational Biologist at Cellecta, Inc. from 2018 to 2021. His earlier experience includes a role as an R&D Scientist at Thermo Fisher Scientific from 2016 to 2017, where he was involved in research and development projects.
Education and Expertise
Russell Darst earned his Doctor of Philosophy (PhD) in Biochemistry and Molecular Genetics from the University of Virginia, where he studied from 1998 to 2002. He also holds a Bachelor of Arts (B.A.) in Biochemistry from Florida State University, completed between 1994 and 1998. His educational background provides a strong foundation for his research interests in epigenetics, chromatin structure, and transcriptional regulation.
Research Focus and Interests
Russell Darst has a keen interest in discovering mathematical relationships within biological data. His research primarily focuses on epigenetics, chromatin structure, and transcriptional regulation. This focus aligns with his work in bioinformatics, where he applies computational techniques to analyze complex biological systems.
Postdoctoral Experience
Russell Darst completed a postdoctoral fellowship at the University of Florida from 2008 to 2014. During this six-year period, he engaged in advanced research that contributed to his expertise in the field of bioinformatics and molecular biology.